The opportunity that precision medicine presents in the field of oncology will be further discussed during this year’s Patient-Centered Oncology Care® 2020 virtual meeting.
The opportunity that precision medicine presents in the field of oncology will be discussed during this year’s Patient-Centered Oncology Care® 2020 virtual meeting, said David Debono, MD, medical director of oncology at Anthem.
AJMC®: What is the overall message you would like to convey to the audience at Patient-Centered Oncology Care® 2020?
Dr Debono: Oncology care in this era of precision medicine, we believe, is a huge opportunity for patients and their families. Anthem health plans are committed to its members, and we are also committed to the oncology community. And we will encourage high-value, precise care for all of its members with cancer.
AJMC®: What is Anthem’s approach to working with community oncology networks?
Dr Debono: We understand that 80% of oncology care is practiced in the community, and we value these oncologists. We understand that community oncologists have a commitment to their patients, to their patients' families, and to their communities. In that vein, we have developed a unique practice engagement model, where we have provider clinical liaisons centered in different regions of the company across the country.
These provider clinical liaisons, who are oncology nurses or oncology pharmacists, are collaborating with oncology practices across Anthem. These liaisons create a very productive relationship with practices where we can discuss our value-based strategies, where we can review our pathways program, and we can review other programs that we are developing within the oncology solutions team.
We are also providing palliative care resources. Palliative care resources are widely available at large institutions and academic centers. However, in the community, palliative care resources are somewhat scattered, if you will. So, we are providing palliative care resources which we believe complement the care that a busy oncologist is providing to its patient and family.
We've also expanded hospice care to allow for patients to receive oncology treatment while they are providing hospice care at the same time. This allows for patients and families not to make that excruciating decision to either continue the treatment that may be continuing to be beneficial or to move toward hospice care.
This hospice expansion allows for patients to continue their treatment and allows for the oncologist to have multiple conversations about high-quality end-of-life care as that patient progresses with their cancer journey.
We think that all these measures keep oncology care in the community and encourage high-quality, high-value care that we know is routinely practiced in the community.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Health Equity and Access Weekly Roundup: May 11, 2024
May 11th 2024This week's topics include frameworks for improving health equity nationwide, addressing social determinants of health, discussing CMS's Medicare rules, investigating breast cancer treatment refusal, and exploring HIV and major depressive disorder in underrepresented groups.
Read More
Reaching Rural America: Value-Based Care Solutions for Systemic Health and Social Inequalities
March 7th 2023On this episode of Managed Care Cast, we speak with Jennifer Schneider, MD, co-founder and chief executive officer of Homeward, a value-based care provider aiming to improve access to high-quality care in rural communities through tech-enabled clinical services, partnerships with local physicians and health plans, and community-level demographic data.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More